PROGRAM OVERVIEW

TARGET AUDIENCE

  • Healthcare professionals and researchers involved in MS clinical care or research.
  • Neurologists
  • Clinical Researchers
  • Residents with interest in Neurology

ACCREDITATION

The Third MENACTRIMS Congress is granted 14.0 CME hours (Category 1) by the Dubai Health Authority (DHA).

HIGHLIGHTS

  • Recent advances in MS therapy
  • MS pathology
  • Immunology of MS
  • Epidemiology of MS
  • MS diagnosis
  • Update on Secondary Progressive MS
  • Neuromyelitis Optica
  • Pediatric MS
  • Biomarkers in MS